Search research articles
Contact Us
Filters
Showing results (191-200 of 265) with videos related to
Page
of 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer
I Osman, H Scher, Z F Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 18, 2001
Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays
C V Hedvat, E S Jaffe, J Qin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1984
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies
Y Fradet, C Cordon-Cardo, T Thomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms
H I Scher, A Sarkis, V Reuter, et al.
International Journal of Cancer
|
October 23, 1997
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides
S Zhang, C Cordon-Cardo, H S Zhang, et al.
Genes & Development
|
July 11, 2001
Mzf1 controls cell proliferation and tumorigenesis
M Gaboli, P A Kotsi, C Gurrieri, et al.
Nature
|
June 12, 1998
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
N Schreiber-Agus, Y Meng, T Hoang, et al.
Cancer Research
|
March 1, 1986
Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines
J Sakamoto, K Furukawa, C Cordon-Cardo, et al.
The American Journal of Surgical Pathology
|
October 1, 1994
Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma
O A Armas, A G Aprikian, J Melamed, et al.
Journal of the National Cancer Institute
|
January 6, 1993
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression
A S Sarkis, G Dalbagni, C Cordon-Cardo, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 265) with videos related to
Sort By:
Page
of 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer
I Osman, H Scher, Z F Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 18, 2001
Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays
C V Hedvat, E S Jaffe, J Qin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1984
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies
Y Fradet, C Cordon-Cardo, T Thomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms
H I Scher, A Sarkis, V Reuter, et al.
International Journal of Cancer
|
October 23, 1997
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides
S Zhang, C Cordon-Cardo, H S Zhang, et al.
Genes & Development
|
July 11, 2001
Mzf1 controls cell proliferation and tumorigenesis
M Gaboli, P A Kotsi, C Gurrieri, et al.
Nature
|
June 12, 1998
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
N Schreiber-Agus, Y Meng, T Hoang, et al.
Cancer Research
|
March 1, 1986
Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines
J Sakamoto, K Furukawa, C Cordon-Cardo, et al.
The American Journal of Surgical Pathology
|
October 1, 1994
Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma
O A Armas, A G Aprikian, J Melamed, et al.
Journal of the National Cancer Institute
|
January 6, 1993
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression
A S Sarkis, G Dalbagni, C Cordon-Cardo, et al.
Page
of 27